Announcements Trials
Browse Landscape

Phase

Phase NA 50Phase 1 31Phase 4 2Phase 3 2Phase 2/3 2Phase 1/2 2Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 551Colorectal Neoplasms 246Neoplasms 232Prostatic Neoplasms 221Carcinoma, Non-Small-Cell Lung 196Stomach Neoplasms 153Leukemia, Myeloid, Acute 149Carcinoma, Hepatocellular 147Lung Neoplasms 136Rectal Neoplasms 135Multiple Myeloma 132Nasopharyngeal Carcinoma 111Colonic Neoplasms 106Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Lymphoma 85Uterine Cervical Neoplasms 83Pancreatic Neoplasms 82Lymphoma, Large B-Cell, Diffuse 79Ovarian Neoplasms 78Leukemia 78Head and Neck Neoplasms 77Esophageal Neoplasms 74Lymphoma, Follicular 72Brain Neoplasms 70Squamous Cell Carcinoma of Head and Neck 65Recurrence 64Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 58Pain 56

Interventions

Quality of Life 1Patient Readmission 1Palliative Care 1Olanzapine 1Needs Assessment 1Coping Skills 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Advanced Cancer × Clear all
NCT06338683 2024-03-29

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Qinghai Red Cross Hospital

Phase 3 Recruiting
230 enrolled

Advanced Cancer

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed
700 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡